Detail of > 7789-77-7
- CAS Number:
- 7789-77-7
- Name:
Phosphoric acid,calcium salt, hydrate (1:1:2)
- Superlist Name:
- Calcium hydrogenphosphate dihydrate
- Formula:
- CaHPO4.2(H2O)
- Molecular Structure:

- Synonyms:
- Emcompress;Emcompress Special;Monohydrogen monocalciumphosphate dihydrate;Parmcompress;Tri-Compress;Phosphoricacid, calcium salt (1:1), dihydrate (8CI,9CI);Bekapress D 2;Bonit;Budit 222;Calcium hydrogen phosphate (CaHPO4) hydrate (1:2);Calcium hydrogen phosphatedihydrate;Calcium monohydrogen orthophosphate dihydrate;Calcium monohydrogenphosphate dihydrate;Calcium phosphate (CaHPO4) dihydrate;Calcium phosphatedihydrate;Calipharm;Dibasic calcium phosphate dihydrate;Calcium hydrogen phosphate;
- Molecular Weight:
- 136.06
- EINECS:
- 231-826-1
- Density:
- 2.31 g/cm3
- Appearance:
- white crystalline solid
- Hazard Symbols:
Xi- Risk Codes:
- 36/37/38
- Safety:
- 26-36Details
Related products
- 7789-77-7Phosphoric acid,calcium salt, hydrate (1:1:2)
- 10031-30-8Phosphoric acid,calcium salt, hydrate (2:1:1)
- 13472-35-0Phosphoric acid, sodiumsalt, hydrate (1:1:2)
- 10103-46-5Phosphoric acid,calcium salt (1:?)
- 13767-12-9Phosphoric acid,calcium salt (3:4)
- 5793-89-5D-Glucaric acid,calcium salt, hydrate (1:1:4)
- 7757-93-9Phosphoric acid,calcium salt (1:1)
- 101836-92-41-Naphthalenol,2,4-dinitro-, sodium salt, hydrate (1:1:2)
Other Products
- Titanium Dioxide Carbon black Glutathione Adenosine Cable pulling lubricant
- 1306-06-5Hydroxyapatite
- 25655-41-8Polyvinylpyrrolidone - iodine complex
- 10039-32-4Disodium phosphate dodecahydrate
- 42986-22-1Benzenesulfonic acid,2-amino-5-[[2-(sulfooxy)ethyl]sulfonyl]-
- 6700-17-0Propanoic acid, sodiumsalt, hydrate (9CI)
- 107-43-7Betaine
- 4075-81-4Propanoicacid, calcium salt (2:1)
- 27176-87-0Laurylbenzenesulfonic acid
- 67-48-1Choline chloride
- 25155-30-0Benzenesulfonic acid,dodecyl-, sodium salt (1:1)
- 590-46-5Methanaminium,1-carboxy-N,N,N-trimethyl-, chloride (1:1)
- 593-81-7Trimethylamine hydrochloride
- 126-96-5Aceticacid, sodium salt (2:1)
- 13717-00-5Australian magnesite
- 7789-77-7Phosphoric acid,calcium salt, hydrate (1:1:2)
Refine Suppliers Do you want your product ranking ahead? Know what is 'Top Seller'!
- Supplier Location:
China (Mainland)(58)
India(6)
United States(5)
Hong Kong(2)
Germany(1)
Canada(1)
Cape Verde(1)
- Business Type:
- Importer/Exporter(59)Manufacturers(3)
- Certificates:
- ISO(4)Production License(4)
Please post your buying leads,so that our qualified suppliers
will soon contact you!
*Required Fields
Reference
- Compressibility and tablet-forming ability of pharmaceuticals
- Compressibility and tablet-forming ability of pharmaceuticals. Jetzer, W.; Leuenberger, H.; Sucker, H. (Pharm. Inst., Univ. Basel, Basel CH-4051, Switz.). Expo. - Congr. Int. Technol. Pharm., 3rd, Volume 4, 55-65. Assoc. Pharm. Galenique Ind.: Chatenay-Malabry, Fr. (French) 1983. CODEN: 53YCA8. DOCUMENT TYPE: Conference CA Section: 63 (Pharmaceuticals) Compression equations are derived for quantifying the compressibility as well as the tablet-forming ability of drugs. The relation between the resistance to deformation of a tablet and the product (pressure against d.) is not linear. The direction of the curve is very rapid at the beginning and then gradually takes the form of a plateau. The aptitude to deformation of a substance is defined by 2 parameters, Pmax and g, representing resistance to max. deformation and susceptibility to compression, resp. The shape of the curve depends on the material used. The parameters Pmax and g are evaluated using single drugs as well as binary mixts. of aspirin [50-78-2], caffeine [58-08-2], Emcompress [7789-77-7], KBr, KCl, lactose [63-42-3] and novalgin [68-89-3].
- Effect of crosslinked PVP on the properties of tableting mixtures and resultant tablets
- Effect of crosslinked PVP on the properties of tableting mixtures and resultant tablets. Hermann, A. M. Guyot; Guyot, J. C. (Lab. Pharm. Galenique Biopharm., Fac. Pharm., Lille 59045, Fr.). Expo. - Congr. Int. Technol. Pharm., 3rd, Volume 4, 44-54. Assoc. Pharm. Galenique Ind.: Chatenay-Malabry, Fr. (French) 1983. CODEN: 53YCA8. DOCUMENT TYPE: Conference CA Section: 63 (Pharmaceuticals) Three different tablet formulations were prepd. each having a different drug, paracetamol [103-90-2], aspirin [50-78-2] and phenacetin [62-44-2] and contg. crosslinked poly(vinylpyrrolidone) (PVP) [9003-39-8]. Encompress [7789-77-7] was used for manuf. of directly compressed paracetamol and phenacetin tablets. Microscopic examn. of the formulations showed good adhesion of PVP particles on the drug crystals and Emcompress. The compression forces decreased with increasing PVP concns. In addn., the thickness of tablets, also decreased with increasing PVP concns. The disintegration times of the tablets were very short and they increased with increasing concn. of PVP. The dissoln. rates also increased with increasing PVP concns. A crit. concn. existed for stabilization of the formulation.
- About us
- |
- Payment
- |
- Contact us
- |
- Links
- |
- Help Center
- |
- Disclaimer
- |
- Add to favorite
- | SiteMap
- |
- Product SiteMap
- |
- Manufacturers
- |
- Suppliers
©2008 LookChem.com,License:ICP NO.:Zhejiang10014259
[Hangzhou]86-571-85317600,85317603,85317620

